![Bioactive lipids S1P/LPA rapidly alter hiPSC morphology and enhance... | Download Scientific Diagram Bioactive lipids S1P/LPA rapidly alter hiPSC morphology and enhance... | Download Scientific Diagram](https://www.researchgate.net/publication/324781725/figure/fig3/AS:619712408977416@1524762360916/Bioactive-lipids-S1P-LPA-rapidly-alter-hiPSC-morphology-and-enhance-vimentin-expression.png)
Bioactive lipids S1P/LPA rapidly alter hiPSC morphology and enhance... | Download Scientific Diagram
![Chemical structure of several natural bioactive lysophospholipids. All... | Download Scientific Diagram Chemical structure of several natural bioactive lysophospholipids. All... | Download Scientific Diagram](https://www.researchgate.net/publication/12233658/figure/fig1/AS:394625589235719@1471097480807/Chemical-structure-of-several-natural-bioactive-lysophospholipids-All-lysophospholipids.png)
Chemical structure of several natural bioactive lysophospholipids. All... | Download Scientific Diagram
![Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain - González de San Román - 2015 - Journal of Neurochemistry - Wiley Online Library Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain - González de San Román - 2015 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/23839c4c-ad1b-46ef-bb67-18f05a1efdc8/jnc13112-fig-0008-m.jpg)
Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain - González de San Román - 2015 - Journal of Neurochemistry - Wiley Online Library
![Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators | Journal of Medicinal Chemistry Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00368/asset/images/medium/jm2c00368_0002.gif)
Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators | Journal of Medicinal Chemistry
Lysophosphatidic Acid-3 Receptor-Mediated Feed-Forward Production of Lysophosphatidic Acid: an Initiator of Nerve Injury-Induced
![Bioactive lipids S1P and LPA enhance β-catenin nuclear accumulation and... | Download Scientific Diagram Bioactive lipids S1P and LPA enhance β-catenin nuclear accumulation and... | Download Scientific Diagram](https://www.researchgate.net/profile/Vahid-Serpooshan/publication/324781725/figure/fig2/AS:619712409001985@1524762360670/Bioactive-lipids-S1P-and-LPA-enhance-b-catenin-nuclear-accumulation-and-activate-Wnt_Q640.jpg)
Bioactive lipids S1P and LPA enhance β-catenin nuclear accumulation and... | Download Scientific Diagram
LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways | PLOS ONE
![Bioactive lipids S1P and LPA enhance β-catenin nuclear accumulation and... | Download Scientific Diagram Bioactive lipids S1P and LPA enhance β-catenin nuclear accumulation and... | Download Scientific Diagram](https://www.researchgate.net/publication/324781725/figure/fig2/AS:619712409001985@1524762360670/Bioactive-lipids-S1P-and-LPA-enhance-b-catenin-nuclear-accumulation-and-activate-Wnt.png)
Bioactive lipids S1P and LPA enhance β-catenin nuclear accumulation and... | Download Scientific Diagram
![Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury - eBioMedicine Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury - eBioMedicine](https://www.thelancet.com/cms/attachment/463a3d99-c33d-4371-94d6-39fcf954f1ef/gr1_lrg.jpg)
Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury - eBioMedicine
![LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/aaf6c549-7f92-4b5a-8f61-e47ebc8b7611/fx1_lrg.jpg)